Published in Proc Natl Acad Sci U S A on November 21, 1995
The enigmatic X gene of hepatitis B virus. J Virol (2004) 2.98
Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol (1998) 1.96
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol (1997) 1.95
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol (1996) 1.89
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol (2001) 1.59
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities. J Virol (2003) 1.47
Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol (1999) 1.46
Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. J Virol (2001) 1.42
Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein. J Virol (2002) 1.40
Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol (2001) 1.32
Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem (2009) 1.27
Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway. Mol Cell Biol (1997) 1.25
The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem (2004) 1.24
Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles. Mol Cell Biol (2003) 1.24
Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis. J Biol Chem (2008) 1.23
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci U S A (1996) 1.19
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol (1998) 1.19
Hepatitis B virus-cell interactions and pathogenesis. J Cell Physiol (2008) 1.17
Pro-apoptotic function of HBV X protein is mediated by interaction with c-FLIP and enhancement of death-inducing signal. EMBO J (2003) 1.16
Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. J Virol (2001) 1.11
Upregulator of cell proliferation predicts poor prognosis in hepatocellular carcinoma and contributes to hepatocarcinogenesis by downregulating FOXO3a. PLoS One (2012) 1.09
Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol (2000) 1.08
Duck hepatitis B virus expresses a regulatory HBx-like protein from a hidden open reading frame. J Virol (2001) 1.08
Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival. Neoplasia (2002) 1.06
HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1. Biochem J (2007) 1.05
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer (2011) 1.05
HBx-DNA probe preparation and its application in study of hepatocarcinogenesis. World J Gastroenterol (1998) 1.03
The hepatitis B virus X protein modulates hepatocyte proliferation pathways to stimulate viral replication. J Virol (2010) 1.02
Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol (2006) 1.01
Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog (2013) 1.00
Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem (2010) 0.99
Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res (2004) 0.96
Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol (2002) 0.95
The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. PLoS One (2012) 0.94
Hepatitis B virus X protein activates the p38 mitogen-activated protein kinase pathway in dedifferentiated hepatocytes. J Virol (2002) 0.94
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1. J Exp Clin Cancer Res (2009) 0.93
Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis. Med Mol Morphol (2009) 0.93
c-ETS1 facilitates G1/S-phase transition by up-regulating cyclin E and CDK2 genes and cooperates with hepatitis B virus X protein for their deregulation. J Biol Chem (2011) 0.93
Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology (2012) 0.92
Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Cancer Res (2008) 0.92
Cyclin-dependent kinase 2 phosphorylates s/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids. J Virol (2012) 0.91
Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma. World J Gastroenterol (2014) 0.91
Different regions of hepatitis B virus X protein are required for enhancement of bZip-mediated transactivation versus transrepression. J Virol (2000) 0.89
Expression of hepatitis B virus X protein in transgenic mice. World J Gastroenterol (2003) 0.89
The HBx oncoprotein of hepatitis B virus deregulates the cell cycle by promoting the intracellular accumulation and re-compartmentalization of the cellular deubiquitinase USP37. PLoS One (2014) 0.85
Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep (2012) 0.85
Differentially expressed genes in hepatocellular carcinoma induced by woodchuck hepatitis B virus in mice. World J Gastroenterol (2001) 0.84
Rich dynamics of a hepatitis B viral infection model with logistic hepatocyte growth. J Math Biol (2009) 0.84
Inducible interleukin 32 (IL-32) exerts extensive antiviral function via selective stimulation of interferon λ1 (IFN-λ1). J Biol Chem (2013) 0.83
miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1. Int J Mol Sci (2012) 0.83
Construction of eukaryotic expression vector of HBV x gene. World J Gastroenterol (1999) 0.83
Cloning of differentially expressed genes in human hepatocellular carcinoma and nontumor liver. World J Gastroenterol (2001) 0.83
Hepatitis B virus X protein impedes the DNA repair via its association with transcription factor, TFIIH. BMC Microbiol (2011) 0.82
Differential effects on apoptosis induction in hepatocyte lines by stable expression of hepatitis B virus X protein. World J Gastroenterol (2006) 0.79
Transfection and expression of hepatitis B virus x gene and its effect on apoptosis in HL-7702 cells. World J Gastroenterol (2004) 0.78
Effect of transforming viruses on molecular mechanisms associated with cancer. J Cell Physiol (2008) 0.78
Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression. PLoS Pathog (2016) 0.78
The viral transactivator HBx protein exhibits a high potential for regulation via phosphorylation through an evolutionarily conserved mechanism. Infect Agent Cancer (2012) 0.77
The aggregation and inheritance of damaged proteins determines cell fate during mitosis. Cell Cycle (2014) 0.76
Hepatocyte Factor JMJD5 Regulates Hepatitis B Virus Replication through Interaction with HBx. J Virol (2016) 0.76
The mitogenic function of hepatitis B virus X protein resides within amino acids 51 to 140 and is modulated by N- and C-terminal regulatory regions. J Virol (2006) 0.76
Hepatitis B virus X protein in liver tumor microenvironment. Tumour Biol (2016) 0.75
Hepatitis B virus X protein mediated suppression of miRNA-122 expression enhances hepatoblastoma cell proliferation through cyclin G1-p53 axis. Infect Agent Cancer (2016) 0.75
An RNAi based high-throughput screening assay to identify small molecule inhibitors of Hepatitis B Virus replication. J Biol Chem (2017) 0.75
Apoptosis in the pathogenesis and treatment of disease. Science (1995) 20.24
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet (1981) 13.54
The molecular biology of the hepatitis B viruses. Annu Rev Biochem (1987) 12.32
Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell (1994) 9.25
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (1992) 6.40
HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (1991) 5.34
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science (1991) 3.78
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci U S A (1994) 3.76
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell (1989) 3.60
Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34
trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol (1988) 3.04
The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A (1993) 2.55
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A (1994) 2.47
Transcriptional trans-activating function of hepatitis B virus. J Virol (1987) 2.46
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J (1995) 2.41
Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A (1993) 2.06
Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol (1992) 2.04
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J Virol (1992) 1.94
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology (1994) 1.74
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci U S A (1995) 1.72
The hepatitis B virus X protein targets the basic region-leucine zipper domain of CREB. Proc Natl Acad Sci U S A (1995) 1.71
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol (1995) 1.63
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol (1994) 1.56
Activation of protooncogene c-jun by the X protein of hepatitis B virus. Virology (1993) 1.50
The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res (1989) 1.45
The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol (1995) 1.36
Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2. J Virol (1990) 1.29
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. Biochem Biophys Res Commun (1991) 1.20
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest (1994) 1.19
Nerve growth factor-treated, neurite-bearing PC12 cells continue to synthesize DNA. J Neurosci (1985) 1.01
Association of casein kinase II with immunopurified p53. Oncogene (1991) 0.99
Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis. Virology (1990) 0.97
Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell (1982) 5.80
Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell (1986) 4.72
Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science (1999) 4.10
Adenovirus VAI RNA prevents phosphorylation of the eukaryotic initiation factor 2 alpha subunit subsequent to infection. Proc Natl Acad Sci U S A (1985) 3.09
Impact of virus infection on host cell protein synthesis. Annu Rev Biochem (1987) 2.98
Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science (2001) 2.98
Adenovirus VAI RNA facilitates the initiation of translation in virus-infected cells. Cell (1984) 2.76
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J (1995) 2.68
Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A (1994) 2.47
Selective translation initiation by ribosome jumping in adenovirus-infected and heat-shocked cells. Genes Dev (1996) 2.42
Selective destabilization of short-lived mRNAs with the granulocyte-macrophage colony-stimulating factor AU-rich 3' noncoding region is mediated by a cotranslational mechanism. Mol Cell Biol (1993) 2.27
Translation by ribosome shunting on adenovirus and hsp70 mRNAs facilitated by complementarity to 18S rRNA. Genes Dev (2000) 2.09
Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C. J Virol (1992) 2.04
Chaperone hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev (2000) 1.92
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol (1996) 1.89
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J (1990) 1.84
Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein. Cell (1991) 1.82
The adenovirus tripartite leader may eliminate the requirement for cap-binding protein complex during translation initiation. J Virol (1988) 1.81
Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci U S A (1997) 1.79
Flattening of proton dose distributions for large-field radiotherapy. Med Phys (1977) 1.68
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol (1996) 1.65
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol (1997) 1.58
Adenovirus-specific translation by displacement of kinase Mnk1 from cap-initiation complex eIF4F. EMBO J (2000) 1.52
Modification of eukaryotic initiation factor 4F during infection by influenza virus. J Virol (1993) 1.48
Src kinases involved in hepatitis B virus replication. EMBO J (1999) 1.47
Primary Eye Care: Are We Giving it Away? Can Fam Physician (1990) 1.39
Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. Am J Trop Med Hyg (1976) 1.35
Role of NF-kappaB and myc proteins in apoptosis induced by hepatitis B virus HBx protein. J Virol (2001) 1.32
Rapid degradation of AU-rich element (ARE) mRNAs is activated by ribosome transit and blocked by secondary structure at any position 5' to the ARE. Mol Cell Biol (1995) 1.30
Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol (1992) 1.27
The role and fate of rabbit and human transcobalamin II in the plasma transport of vitamin B12 in the rabbit. J Clin Invest (1976) 1.27
Translation by the adenovirus tripartite leader: elements which determine independence from cap-binding protein complex. J Virol (1990) 1.25
Human plasma R-type vitamin B12-binding proteins. II. The role of transcobalamin I, transcobalamin III, and the normal granulocyte vitamin B12-binding protein in the plasma transport of vitamin B12. J Biol Chem (1975) 1.25
Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation. Mol Cell Biol (1996) 1.24
Isolation of a biologically active macrophage receptor for the third component of complement. Nature (1981) 1.24
An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol Cell Biol (1986) 1.22
A late adenovirus factor induces eIF-4E dephosphorylation and inhibition of cell protein synthesis. J Virol (1994) 1.21
Hepatitis B virus HBx protein activation of cyclin A-cyclin-dependent kinase 2 complexes and G1 transit via a Src kinase pathway. J Virol (2001) 1.20
Adenovirus inhibition of cell translation facilitates release of virus particles and enhances degradation of the cytokeratin network. J Virol (1994) 1.12
Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer (1980) 1.12
Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine. Proc Natl Acad Sci U S A (1990) 1.11
Secondary structure analysis of adenovirus tripartite leader. J Biol Chem (1989) 1.00
Serous detachment of the macula. Can J Ophthalmol (1970) 0.99
Adenovirus induction of an interferon-regulatory factor during entry into the late phase of infection. J Virol (1998) 0.96
A syndrome of brain, inner ear and retinal microangiopathy. Can J Neurol Sci (1987) 0.96
Kinetics of transfer of Escherichia coli single strand deoxyribonucleic acid binding protein between single-stranded deoxyribonucleic acid molecules. Biochemistry (1982) 0.95
Characterization of ligand-binding activity of isolated murine Fc gamma receptor. J Immunol (1981) 0.95
A survey of Thai student use of illicit drugs. Int J Addict (1977) 0.93
Preferential translation of adenovirus mRNAs in infected cells. Cold Spring Harb Symp Quant Biol (2001) 0.93
Clinical sequelae after japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health (1974) 0.90
Differential contributions of spinal pathways to body representation in postcentral gyrus of Macaca mulatta. J Neurophysiol (1974) 0.89
Effect of long term organic amendments on adsorption-desorption of thiram onto a luvisol soil derived from loess. Chemosphere (2010) 0.88
Proton irradiation of choroidal melanomas. Preliminary results. Arch Ophthalmol (1978) 0.88
Factors relating to transmission of viral hepatitis in a United States military population stationed in Thailand. Am J Epidemiol (1981) 0.86
Retinal burn from a welding arc. Can J Ophthalmol (1978) 0.85
Orbital involvement in Riedel's struma. Can J Ophthalmol (1976) 0.81
Calcium-induced stabilization of AU-rich short-lived mRNAs is a common default response. Gene Expr (1999) 0.81
The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. Southeast Asian J Trop Med Public Health (1975) 0.81
Inhibition of Cap-initiation complexes linked to a novel mechanism of eIF4G depletion in acute myocardial ischemia. Cell Death Differ (2006) 0.81
Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol (1988) 0.80
Immunohistochemical detection of hepatitis C antigen by monoclonal antibody TORDJI-22 compared with PCR viral detection. Am J Clin Pathol (1998) 0.80
Median nerve evoked potential changes in an acute carpal tunnel syndrome model in Macaca mulatta. Electroencephalogr Clin Neurophysiol (1983) 0.80
Proprioceptive pathways of the spinal cord. J Neurol Neurosurg Psychiatry (1977) 0.79
Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic hypernephroma. Cancer Treat Rep (1980) 0.78
Effect of acute compartmental pressure change on response to vibratory stimuli in primates. Plast Reconstr Surg (1983) 0.78
Role of Ser-53 phosphorylation in the activity of human translation initiation factor eIF-4E in mammalian and yeast cells. Gene (1995) 0.78
Clinical inference in nursing; information units used. Nurs Res (1966) 0.78
Quantification of flow in a dynamic phantom using Rb81-Kr81m, and a Nal detector. J Nucl Med (1977) 0.78
Haemosiderin deposits in the human cornea. J Submicrosc Cytol (1981) 0.77
The determination of absorbed dose in a proton beam for purposes of charged-particle radiation therapy. Radiat Res (1979) 0.76
Proton irradiation of malignant melanoma of the ciliary body. Br J Ophthalmol (1979) 0.75
Hair follicle discrimination dysfunction in multiple sclerosis patients. J Neurol Neurosurg Psychiatry (1982) 0.75
Incidence of daily drug use as reported by a population of Thai partners working near United States military installations: a preliminary study. Int J Addict (1976) 0.75
Family education in the workplace: A prevention program for working parents and school-age children. J Prim Prev (1994) 0.75
Coordinating EMS through telecommunications. Emerg Health Serv Q (1981) 0.75
Effectiveness of a prehospital medical control system: an analysis of the interaction between emergency room physician and paramedic. Circulation (1981) 0.75
Measurements and calculations of the influence of thin inhomogeneities on charged particle beams. Med Phys (1978) 0.75
Isolated bilateral complete ptosis. Can J Ophthalmol (1983) 0.75
Doctor, are you good enough? Can J Ophthalmol (1989) 0.75
Low temperature painful stimulus alters brain wave pattern of transcutaneous electrical stimulus. Life Sci (1981) 0.75
Eye care: who cares? Can J Ophthalmol (1988) 0.75
Note on differential payoff and time-cost functions in choice reaction time. Percept Mot Skills (1968) 0.75
Father-distance and drug abuse in young men. J Nerv Ment Dis (1977) 0.75
Phase II trial of AMSA in previously treated patients with stage III and IV ovarian cancer. Cancer Treat Rep (1982) 0.75
Glibenclamide binding in vertebrate cardiac membranes. J Exp Biol (1993) 0.75
Disaster, psychiatric casualties and implications for future war. J R Army Med Corps (1982) 0.75
Vox populi and senile macular degeneration. Can J Ophthalmol (1982) 0.75
Marbe's law, stimulus expectancy, and response competition. Am J Psychol (1972) 0.75
Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule. Cancer Treat Rep (1980) 0.75
Production of rubidium-81 by the reaction 85Rb(p, 5n) 81Sr and decay of 81Sr. Int J Appl Radiat Isot (1976) 0.75
Quantification of cells with specific phenotypes II: determination of CD4 expression level on reconstituted lyophilized human PBMC labelled with anti-CD4 FITC antibody. Cytometry A (2015) 0.75
Low temperature stimulation augments early wave component of somatosensory evoked response in humans and Macaca mulatta monkeys. Pain (1982) 0.75
Pupillary response to light as an indicator of functional psychoses: a failure to replicate. J Nerv Ment Dis (1966) 0.75
Posterior column sensory mapping. Surg Forum (1978) 0.75
Clinical inference in nursing: revising judgments. Nurs Res (1967) 0.75
Battle stress reaction and the United States Army. Mil Med (1984) 0.75
Clinical inference in nursing. Analyzing cognitive tasks representative of nursing problems. Nurs Res (1966) 0.75